Doctors applaud suzetrigine as non-dependent alternative for pain management
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients.
Journavx (suzetrigine), made by Vertex, is the "first and only approved non-opioid oral pain signal inhibitor," according to a press release from the Massachusetts-based company.
Read Article
#EmergingDrugTrends#Suzetrigine